Development of a consensus-base list of criteria for prescribing medication in a pediatric population

A Guérin1, J F Bussières2,3, R Boulkedid4,5

  • 1Pharmacy Practice Research Unit, Pharmacy Department, Sainte-Justine University Health Center, 3175, chemin de la Côte Sainte-Catherine, Montreal, Quebec, H3T 1C5, Canada. aurelieguerin01@gmail.com.

Insights

This study developed a consensus-based tool to assess pediatric medication safety. The CIRCUS tool helps evaluate and improve best practices in the pediatric drug-use process, enhancing patient safety.

Area of Science:

  • Pediatric Pharmacology
  • Patient Safety
  • Health Informatics

Background:

  • Medication use in children carries significant risks of adverse events.
  • The pediatric population is particularly vulnerable to medication-related harm.
  • Optimizing the medication-use process is crucial for pediatric patient safety.

Purpose of the Study:

  • To develop a consensus-based list of criteria for the pediatric medication-use process safety.
  • To create the CIRCUS tool (CIRcuit-of-Child-drug-USe) for self-assessment of safety practices.
  • To establish a standardized method for evaluating pediatric drug safety.

Main Methods:

  • A multicenter approach involving experts from eight university hospitals.
  • A comprehensive literature search (1998-2013) identified 26 safety practice domains.
  • A two-round Delphi survey with 24 French-speaking multidisciplinary panelists (doctors, pharmacists, nurses) to rate 48 compliance criteria.

Main Results:

  • A 92% participation rate was achieved, with 22 professionals completing the survey.
  • Consensus was reached on 38 out of 48 (79%) safety practice compliance criteria.
  • The consensus criteria were organized into 23 distinct domains.

Conclusions:

  • A self-assessment tool, the CIRCUS tool, was developed for pediatric drug-use safety practices.
  • The CIRCUS tool utilizes a Delphi method for consensus-based criterion development.
  • This tool can be used to record and compare the prevalence of best safety practices in pediatric medication management.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
868
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
388
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
821
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
497
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
352
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K